EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

USP32 Promotes Colorectal Carcinoma Progression Through Activating NF ‐ κB Signalling Pathway

Xiaofan Duan, Gaoshaer Yeerkenbieke, Siping Huang, Yanjun Feng iD

Journal of Cellular and Molecular Medicine · 2025

DOI: 10.1111/jcmm.70457 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Xiaofan Duan und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, NF-kappa B, Signal Transduction, Ubiquitin Thiolesterase. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wu Jieping Medical Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ubiquitin‐specific protease 32 (USP32) plays a key role in cancer progression. However, its functions in colorectal carcinoma (CRC) are still unexplored. In our study, we explored the expression and clinical significance of USP32 in CRC as well as its relationship with the tumour microenvironment (TME). As a result, we found that USP32 is overexpressed in CRC and it is associated with poor outcomes in CRC patients. In addition, the expression of USP32 is significantly related to the activation of the NF‐κB signalling pathway and the immune infiltrates of the TME. Wet experiments also confirmed that USP32 is critical for the proliferation, survival, and migration of CRC cells and tumour growth, which may be due to the activation of the NF‐κB signalling pathway. In conclusion, targeting the USP32–NF‐κB axis may be a novel treatment strategy for CRC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsNF-kappa BSignal TransductionUbiquitin ThiolesteraseHumansDisease ProgressionCell ProliferationGene Expression Regulation, NeoplasticTumor MicroenvironmentFemaleAnimalsCell Line, TumorMaleCell MovementMiceMiddle AgedPrognosis

Stichwörter der Autor:innen

NF‐κB signalling pathwayUSP32colorectal carcinomaimmunotherapytumour environment

Substanzen

NF-kappa BUbiquitin Thiolesterase

Autor:innen und Institutionen

  • School of Medicine, Tongji University, Shanghai, China.
  • Department of Oncology, Shanghai GoBroad Cancer Hospital, China Pharmaceutical University, Shanghai, China.
  • Department of surgical oncology, Shanghai GoBroad Cancer Hospital, China Pharmaceutical University, Shanghai, China.
  • Shanghai East Hospital, Nanjing Medical University, Shanghai, China.
  • Department of Oncology, Shanghai Artemed Hospital, Shanghai, China.

ORCID-Profile: Yanjun Feng

Förderung

  • Wu Jieping Medical Foundation

Zitieren

APA

Duan, X., Yeerkenbieke, G., Huang, S., & Feng, Y. (2025). USP32 Promotes Colorectal Carcinoma Progression Through Activating NF ‐ κB Signalling Pathway. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70457

Vancouver

Duan X, Yeerkenbieke G, Huang S, Feng Y. USP32 Promotes Colorectal Carcinoma Progression Through Activating NF ‐ κB Signalling Pathway. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70457

BibTeX
@article{Duan2025,
  author = {Duan, Xiaofan and Yeerkenbieke, Gaoshaer and Huang, Siping and Feng, Yanjun},
  title = {USP32 Promotes Colorectal Carcinoma Progression Through Activating NF ‐ κB Signalling Pathway},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  doi = {10.1111/jcmm.70457}
}
Kostenlos starten →